MARKETS LIVE
Loading markets…
Thursday, June 11, 2026 U.S. Edition

Moderna, Inc. MRNA

Loading live quote…
$49.64 +3.65 (+7.94%)
Price Chart
About Moderna, Inc.

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic…

Recent Quarters
QuarterRevenueNet IncomeEPS (dil.)Gross Margin
2026 Q1 $-1,343,000,000 -3.40 -145.5%
2025 Q4 $-826,000,000 -2.11 33.1%
2025 Q3 $-200,000,000 -0.51 79.3%
2025 Q2 $-825,000,000 -2.13 13.1%